Davide Giuseppe Ribaldone

Author

Also Known As

D G Ribaldone, D Giuseppe Ribaldone, D Ribaldone, D. G. Ribaldone, D. Ribaldone, D.G. Ribaldone, Daniela Pugliese, Davide G Ribaldone, Davide G. RIBALDONE, Davide G. Ribaldone

394

Publications

Citations

H-Index

125

Concepts

All Affiliations

University of Turin Fondazione Ricerca Molinette Humanitas University Azienda Ospedaliera Citta' della Salute e della Scienza di Torino Istituti di Ricovero e Cura a Carattere Scientifico

About

Davide Giuseppe Ribaldone is an author at University of Turin specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	32	992
2	Health Sciences	7	7	193
3	Public Health	4	4	212
4	Engineering	1	1	19
5	Allergy	1	1	22

Davide Giuseppe Ribaldone

100

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study Cristina Bezzio, Simone Saibeni, Angela Variola, Gut	2020	329
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. Rinaldo Pellicano, Davide Giuseppe Ribaldone, Sharmila Fagoonee, PubMed AntibioticsAcid ResistanceMedicineClinical EpidemiologyGastroenterology	2016	151
Serum zonulin in patients with inflammatory bowel disease: a pilot study Gian Paolo Caviglia, Francesca Dughera, Davide Giuseppe Ribaldone, Minerva Medica	2019	109
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agents Alessia Ciancio, Roberta Bosio, Simona Bo, Journal of Medical Virology Significant ImprovementAntiviral DrugChronic Hepatitis CMetabolic SyndromeDiabetes Epidemiology	2017	97
Dual Targeted Therapy: A Possible Option for the Management of Refractory Inflammatory Bowel Disease Giuseppe Privitera, Sara Onali, Daniela Pugliese, Journal of Crohn s and Colitis	2020	81
Physiopathology of intestinal barrier and the role of zonulin Gian Paolo Caviglia, Chiara Rosso, Davide Giuseppe Ribaldone, Minerva Biotecnologica InflammationIntestinal Permeability RegulationAutoimmune DiseaseMucosal ImmunologyMedicine	2019	77
Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn’s Disease Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Amina Abdulle, Journal of Clinical Medicine	2019	70
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study Marta Vernero, Federico De Blasio, Davide Giuseppe Ribaldone, Journal of Clinical Medicine	2020	69
Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy Gian Paolo Caviglia, Angela Garrone, Chiara Bertolino, Journal of Clinical Medicine	2023	67
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune‐mediated inflammatory diseases: A European retrospective observational study Laurent Goessens, Jean‐Frédéric Colombel, An Outtier, United European Gastroenterology Journal	2021	66

Page 1